Article in IMA fungus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Manuela Agudelo-RestrepoDepartment of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), and German Centre for Infection Research Association (DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany Helmholtz Centre for Infection Research GmbH (HZI), and German Centre for Infection Research Association (DZIF) Braunschweig Germany.ORCID https://orcid.org/0009-0003-5842-202X
Margarita Hernández-RestrepoWesterdijk Fungal Biodiversity Institute, Uppsalalaan 8, 3584CT, Utrecht, Netherlands Westerdijk Fungal Biodiversity Institute Utrecht Netherlands.ORCID https://orcid.org/0000-0001-5157-3392
Mahmoud A A IbrahimComputational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt Minia University Minia Egypt.ORCID https://orcid.org/0000-0003-4819-2040
Esteban Charria-GirónDepartment of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), and German Centre for Infection Research Association (DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany Helmholtz Centre for Infection Research GmbH (HZI), and German Centre for Infection Research Association (DZIF) Braunschweig Germany.ORCID https://orcid.org/0000-0002-3823-1416
Sherif S EbadaDepartment of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), and German Centre for Infection Research Association (DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany Helmholtz Centre for Infection Research GmbH (HZI), and German Centre for Infection Research Association (DZIF) Braunschweig Germany.ORCID https://orcid.org/0000-0002-2753-0031
Yasmina Marin-FelixDepartment of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), and German Centre for Infection Research Association (DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany Helmholtz Centre for Infection Research GmbH (HZI), and German Centre for Infection Research Association (DZIF) Braunschweig Germany.ORCID https://orcid.org/0000-0001-8045-4798
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.